Respiratory Syncytial Virus (RSV) is the most common respiratory virus in infants and young children. It infects virtually all infants by the age of 2. In most cases, the virus causes symptoms resembling the common cold. Most children recover in 8 to 15 days. However, in children born prematurely and/or with chronic lung disease, RSV can cause a severe, life-threatening disease. Each year, 125,000 infants in the United States are hospitalized with severe RSV infections, the leading cause of infant hospitalization.
The Synagis Clinic at Children’s Hospital & Research Center Oakland provides RSV prophylaxis (protection), using Synagis, an FDA-approved monoclonal anti-RSV antibody, during the regional RSV season, which lasts from November through April. The following patients are eligible for the Synagis Clinic:
• Infants younger than 2 years with chronic lung disease (CLD) who have required medical therapy for their CLD within six months of the start of the RSV season
• Infants who were born at less than 28 weeks gestational age and who are younger than 1 year at the start of the RSV season
• Infants who were born at 29 to 32 weeks gestational age and who are younger than 6 months at the start of RSV season.
Please ask your primary care physician, or call (510) 428-3885, Ext. 2914.
Call for seasonal hours.
Phone: (510) 428-3885, Ext. 2914.
Fax: (510) 597-7125
Where to find us
Outpatient Center (OPC) — Map/Directions
744 52nd St., Oakland, CA 94609